1. López-Giraldo A, Rodríguez-Roisin R, Agustí A. Chronic obstructive pulmonary disease: The golden decade. Implications for the diagnosis, prevention and treatment of chronic obstructive pulmonary disease. Medicina Clínica. 2015;144(11):507–13. DOI: 10.1016/j.medcli.2014.03.009
2. Huiart L, Ernst P, Suissa S. Cardiovascular Morbidity and Mortality in COPD. Chest. 2005;128(4):2640–6. DOI: 10.1378/chest.128.4.2640
3. Maclay JD, MacNee W. Cardiovascular Disease in COPD. Chest. 2013;143(3):798–807. DOI: 10.1378/chest.12-0938
4. Yoshizawa T, Hosokawa Y, Hashimoto S, Okada K, Furuichi S, Ishiguro T et al. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels. International Journal of Chronic Obstructive Pulmonary Disease. 2015;10:1283–9. DOI: 10.2147/COPD.S80673
5. Andrassy KM. Comments on ‘KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.’ Kidney International. 2013;84(3):622–3. DOI: 10.1038/ki.2013.243
6. Cardiovascular risk and chronic kidney disease: strategies for cardio-nephroprotection. Clinical nephrology. 2014;2:4–29.
7. Bouillanne O, Morineau G, Dupont C, Coulombel I, Vincent J-P, Nicolis I et al. Geriatric Nutritional Risk Index: a new index for evaluating atrisk elderly medical patients. The American Journal of Clinical Nutrition. 2005;82(4):777–83. DOI: 10.1093/ajcn/82.4.777
8. Freund N, Friedli BC, Junker T, Zimmermann M, Zellweger MJ. Cardiovascular Risk Assessment and Effects on Behavior in Switzerland The Swiss Heart Foundation HerzCheck ®/Cardio-Test®. The Open Cardiovascular Medicine Journal. 2015;9(1):35–9. DOI: 10.2174/1874192401509010035
9. Romanens M, Mortensen MB, Sudano I, Szucs T, Adams A. Extensive carotid atherosclerosis and the diagnostic accuracy of coronary risk calculators. Preventive Medicine Reports. 2017;6:182–6. DOI: 10.1016/j.pmedr.2017.03.006
10. Konecny T, Somers KR, Park JY, John A, Orban M, Doshi R et al. Chronic obstructive pulmonary disease as a risk factor for ventricular arrhythmias independent of leſt ventricular function. Heart Rhythm. 2018;15(6):832–8. DOI: 10.1016/j.hrthm.2017.09.042
11. Lin H-W, Chung C-L, Lin YS, Yu C-M, Lee C-N, Bien M-Y. Inhaled Pharmacotherapy and Stroke Risk in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population Based Study Using Two-Stage Approach. PLOS ONE. 2015;10(7):e0130102. DOI: 10.1371/journal.pone.0130102
12. Portegies MLP, Lahousse L, Joos GF, Hofman A, Koudstaal PJ, Stricker BH et al. Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study. American Journal of Respiratory and Critical Care Medicine. 2016;193(3):251–8. DOI: 10.1164/rccm.201505-0962OC
13. Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. The Lancet Respiratory Medicine. 2015;3(8):631–9. DOI: 10.1016/S2213-2600(15)00241-6
14. Chen W-J, Lin C-C, Lin C-Y, Chang Y-J, Sung F-C, Kao C-H et al. Pulmonary Embolism in Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2014;11(4):438–43. DOI: 10.3109/15412555.2013.813927
15. Donaldson GC, Hurst JR, Smith CJ, Hubbard RB, Wedzicha JA. Increased Risk of Myocardial Infarction and Stroke Following Exacerbation of COPD. Chest. 2010;137(5):1091–7. DOI: 10.1378/chest.09-2029
16. Halpin DMG, Decramer M, Celli B, Kesten S, Leimer I, Tashkin DP. Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT® Trial. Lung. 2011;189(4):261–8. DOI: 10.1007/s00408-011-9301-8
17. Quint J, Windsor C, Herrett E, Smeeth L. No association between exacerbation frequency and stroke in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease. 2016;11:217–25. DOI: 10.2147/COPD.S95775
18. Can U, Yerlikaya FH, Yosunkaya S. Role of oxidative stress and serum lipid levels in stable chronic obstructive pulmonary disease. Journal of the Chinese Medical Association. 2015;78(12):702–8. DOI: 10.1016/j. jcma.2015.08.004
19. Li C, Yan L, Xu J. Correlations between lipid ratio/oxidative stress status in COPD patients and pulmonary hypertension as well as prognosis. Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences. 2016;41(11):1168–74. DOI: 10.11817/j.issn.1672-7347.2016.11.009
20. Gunay S, Sariaydin M, Acay A. New Predictor of Atherosclerosis in Subjects With COPD: Atherogenic Indices. Respiratory Care. 2016;61(11):1481–7. DOI: 10.4187/respcare.04796
21. Esteve E, Ricart W, Fernández-Real JM. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clinical Nutrition. 2005;24(1):16–31. DOI: 10.1016/j.clnu.2004.08.004
22. Morgan AD, Zakeri R, Quint JK. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Therapeutic Advances in Respiratory Disease. 2018;12:175346581775052. DOI: 10.1177/1753465817750524
23. Roversi S, Roversi P, Spadafora G, Rossi R, Fabbri LM. Coronary artery disease concomitant with chronic obstructive pulmonary disease. European Journal of Clinical Investigation. 2014;44(1):93–102. DOI: 10.1111/eci.12181
24. Yoo SH, Kook HY, Hong YJ, Kim JH, Ahn Y, Jeong MH. Influence of undernutrition at admission on clinical outcomes in patients with acute myocardial infarction. Journal of Cardiology. 2017;69(3):555–60. DOI: 10.1016/j. jjcc.2016.05.009
25. Huang B-T, Peng Y, Liu W, Zhang C, Chai H, Huang F-Y et al. Nutritional state predicts all-cause death independent of comorbidities in geriatric patients with coronary artery disease. The journal of nutrition, health & aging. 2016;20(2):199–204. DOI: 10.1007/s12603-015-0572-2
26. Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. The Lancet. 2014;383(9921):970–83. DOI: 10.1016/S0140-6736(13)61836-X
27. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of All-Cause Mortality with Overweight and Obesity Using Standard Body Mass Index Categories: A Systematic Review and Meta-analysis. JAMA. 2013;309(1):71–82. DOI: 10.1001/jama.2012.113905
28. Editorial A. Evaluation of nutritional status and nutritional therapy in chronic obstructive pulmonary disease. Russian Pulmonology. 2016;26(1):13–28.. DOI: 10.18093/0869-0189-2016-26-1-13-28
29. Reboldi G, Verdecchia P, Fiorucci G, Beilin LJ, Eguchi K, Imai Y et al. Glomerular hyperfiltration is a predictor of adverse cardiovascular outcomes. Kidney International. 2018;93(1):195–203. DOI: 10.1016/j. kint.2017.07.013
30. Eisen A, Hoshen M, Balicer RD, Reges O, Rabi Y, Leibowitz M et al. Estimated Glomerular Filtration Rate Within the Normal or Mildly Impaired Range and Incident Cardiovascular Disease. The American Journal of Medicine. 2015;128(9):1015-1022.e2. DOI: 10.1016/j.amjmed.2015.03.024
31. Bolotova E. V., Dudnikova A. V. Method for early diagnostics of chronic kidney disease in patients with chronic obstructive pulmonary disease. RU2647327C2.
32. Janssens W, Bouillon R, Claes B, Carremans C, Lehouck A, Buysschaert I et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax. 2010;65(3):215–20. DOI: 10.1136/thx.2009.120659
33. Lee HM, Liu M, Lee K, Luo Y, Wong ND. Does Low Vitamin D Amplify the Association of COPD With Total and Cardiovascular Disease Mortality? Clinical Cardiology. 2014;37(8):473–8. DOI: 10.1002/clc.22284
34. Durup D, Jørgensen HL, Christensen J, Tjønneland A, Olsen A, Halkjær J et al. A Reverse J-Shaped Association Between Serum 25-Hydroxyvitamin D and Cardiovascular Disease Mortality: The CopD Study. The Journal of Clinical Endocrinology & Metabolism. 2015;100(6):2339–46. DOI: 10.1210/jc.2014-4551